Oncology Drugs Market Research Report, Growth & Forecast

According to our (Global Info Research) latest study, the global Reritinib Mesylate Tablets market size was valued at US$ 36.01 million in 2025 and is forecast to a readjusted size of US$ 122 million...

According to our (Global Info Research) latest study, the global Sacituzumab Govitecan market size was valued at US$ 144 million in 2025 and is forecast to a readjusted size of US$ 639 million by 2032...

According to our (Global Info Research) latest study, the global Tagolimab market size was valued at US$ 45.69 million in 2025 and is forecast to a readjusted size of US$ 649 million by 2032 with a CA...

According to our (Global Info Research) latest study, the global Taletrectinib Adipate market size was valued at US$ 46.30 million in 2025 and is forecast to a readjusted size of US$ 436 million by 20...

According to our (Global Info Research) latest study, the global Tisotumab Vedotin market size was valued at US$ 432 million in 2025 and is forecast to a readjusted size of US$ 1429 million by 2032 wi...

According to our (Global Info Research) latest study, the global Toripalimab market size was valued at US$ 329 million in 2025 and is forecast to a readjusted size of US$ 896 million by 2032 with a CA...

The global Acalabrutinib Maleate market size is expected to reach $ 10679 million by 2032, rising at a market growth of 17.9% CAGR during the forecast period (2026-2032). Acalabrutinib Maleate is the...

The global Almonertinib Mesylate market size is expected to reach $ 700 million by 2032, rising at a market growth of 17.4% CAGR during the forecast period (2026-2032). In 2025, global production of a...

The global Anti-androgen Drugs market size is expected to reach $ 17964 million by 2032, rising at a market growth of 12.2% CAGR during the forecast period (2026-2032). Anti-androgen drugs are a class...

The global Befotertinib Mesylate market size is expected to reach $ 2289 million by 2032, rising at a market growth of 24.4% CAGR during the forecast period (2026-2032). Befotertinib mesylate is a thi...

The global Belzutifan market size is expected to reach $ 1637 million by 2032, rising at a market growth of 10.0% CAGR during the forecast period (2026-2032). In 2025, global Belzutifan production rea...

The global Biciruizumab market size is expected to reach $ 8879 million by 2032, rising at a market growth of 14.6% CAGR during the forecast period (2026-2032). Bevacizumab is a recombinant humanized...

The global Capmatinib Hydrochloride Tablets market size is expected to reach $ 1195 million by 2032, rising at a market growth of 12.6% CAGR during the forecast period (2026-2032). In 2025, global Cap...

The global CMAB009 market size is expected to reach $ 252 million by 2032, rising at a market growth of 7.3% CAGR during the forecast period (2026-2032). CMAB009 is a recombinant chimeric anti?epiderm...

The global Differentiated Abiraterone Formulations market size is expected to reach $ 853 million by 2032, rising at a market growth of 7.0% CAGR during the forecast period (2026-2032). Differentiated...

The global Donafenib Tosylate market size is expected to reach $ 97 million by 2032, rising at a market growth of 5.9% CAGR during the forecast period (2026-2032). In 2025, global production of donafe...

The global Enfortumab Vedotin?ejfv market size is expected to reach $ 5424 million by 2032, rising at a market growth of 13.5% CAGR during the forecast period (2026-2032). Vandetanib is an oral small...

The global Enlonstobart market size is expected to reach $ 66.91 million by 2032, rising at a market growth of 6.2% CAGR during the forecast period (2026-2032). Enlonstobart is a fully human anti?PD?1...

The global Erdafitinib Tablets market size is expected to reach $ 523 million by 2032, rising at a market growth of 9.2% CAGR during the forecast period (2026-2032). Erdafitinib is an oral, highly sel...

The global Famitinib Malate Capsules market size is expected to reach $ 42.99 million by 2032, rising at a market growth of 6.2% CAGR during the forecast period (2026-2032). Famitinib malate is an ora...

The global Flumatinib Mesylate market size is expected to reach $ 547 million by 2032, rising at a market growth of 33.5% CAGR during the forecast period (2026-2032). In 2025, global production of flu...

The global Fruquintinib market size is expected to reach $ 1379 million by 2032, rising at a market growth of 14.6% CAGR during the forecast period (2026-2032). In 2025, global production of fruquinti...

The global Furmonertinib Mesylate market size is expected to reach $ 1934 million by 2032, rising at a market growth of 11.6% CAGR during the forecast period (2026-2032). In 2025, global Furmonertinib...

The global Golidocitinib market size is expected to reach $ 968 million by 2032, rising at a market growth of 16.3% CAGR during the forecast period (2026-2032). Golidocitinib is a highly selective, or...

The global Hyperthermic Chemotherapy Perfusion System market size is expected to reach $ 64.33 million by 2032, rising at a market growth of 4.7% CAGR during the forecast period (2026-2032). A Hyperth...

The global Inavolisib Tablets market size is expected to reach $ 940 million by 2032, rising at a market growth of 22.5% CAGR during the forecast period (2026-2032). Inavolisib is an orally administer...

The global Inetetamab market size is expected to reach $ 990 million by 2032, rising at a market growth of 19.5% CAGR during the forecast period (2026-2032). Inetetamab is a recombinant humanized mono...

The global Iparomlimab market size is expected to reach $ 316 million by 2032, rising at a market growth of 15.7% CAGR during the forecast period (2026-2032). Iparomlimab is a humanized monoclonal ant...

The global Isatuximab market size is expected to reach $ 1740 million by 2032, rising at a market growth of 13.8% CAGR during the forecast period (2026-2032). Isatuximab is a humanized monoclonal anti...

The global Lerociclib Hydrochloride Tablets market size is expected to reach $ 318 million by 2032, rising at a market growth of 18.5% CAGR during the forecast period (2026-2032). Lerociclib Hydrochlo...

The global Mirvetuximab Soravtansine market size is expected to reach $ 2621 million by 2032, rising at a market growth of 15.9% CAGR during the forecast period (2026-2032). Mirvetuximab Soravtansine...

The global Momelotinib tablets market size is expected to reach $ 763 million by 2032, rising at a market growth of 44.9% CAGR during the forecast period (2026-2032). Momelotinib tablets are an orally...

The global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size is expected to reach $ 18278 million by 2032, rising at a market growth of 20.4% CAGR during the forecast period (2026-2032)....

The global Pamiparib market size is expected to reach $ 422 million by 2032, rising at a market growth of 10.9% CAGR during the forecast period (2026-2032). In 2025, global Pamiparib production reache...

The global Poly ADP-ribose Polymerase Inhibitors(PARP Inhibitors) market size is expected to reach $ 26465 million by 2032, rising at a market growth of 15.4% CAGR during the forecast period (2026-203...

The global PSMA-labeled Imaging Ligands market size is expected to reach $ 12023 million by 2032, rising at a market growth of 22.8% CAGR during the forecast period (2026-2032). Prostate-specific memb...

The global Pyrotinib Maleate market size is expected to reach $ 497 million by 2032, rising at a market growth of 9.8% CAGR during the forecast period (2026-2032). In 2025, global Pyrotinib Maleate pr...

The global Reritinib Mesylate Tablets market size is expected to reach $ 122 million by 2032, rising at a market growth of 6.7% CAGR during the forecast period (2026-2032). Reritinib Mesylate Tablets...

The global Sacituzumab Govitecan market size is expected to reach $ 639 million by 2032, rising at a market growth of 15.6% CAGR during the forecast period (2026-2032). Sacituzumab Govitecan is a Trop...

The global Tagolimab market size is expected to reach $ 649 million by 2032, rising at a market growth of 24.4% CAGR during the forecast period (2026-2032). Tagolimab is a monoclonal antibody currentl...

The global Taletrectinib Adipate market size is expected to reach $ 436 million by 2032, rising at a market growth of 25.2% CAGR during the forecast period (2026-2032). Taletrectinib Adipate is an ora...

The global Tisotumab Vedotin market size is expected to reach $ 1429 million by 2032, rising at a market growth of 16.7% CAGR during the forecast period (2026-2032). Tisotumab vedotin is an antibody-d...

The global Toripalimab market size is expected to reach $ 896 million by 2032, rising at a market growth of 13.4% CAGR during the forecast period (2026-2032). Toripalimab is a humanized IgG4 monoclona...

According to our (Global Info Research) latest study, the global Disitamab Vedotin market size was valued at US$ 329 million in 2025 and is forecast to a readjusted size of US$ 1181 million by 2032 wi...

According to our (Global Info Research) latest study, the global Ribociclib Succinate Tablets market size was valued at US$ 3087 million in 2025 and is forecast to a readjusted size of US$ 8448 millio...

According to our (Global Info Research) latest study, the global Selicrelumab market size was valued at US$ 28.09 million in 2025 and is forecast to a readjusted size of US$ 122 million by 2032 with a...

According to our (Global Info Research) latest study, the global Tafasitamab market size was valued at US$ 350 million in 2025 and is forecast to a readjusted size of US$ 812 million by 2032 with a CA...

The global Disitamab Vedotin market size is expected to reach $ 1181 million by 2032, rising at a market growth of 16.9% CAGR during the forecast period (2026-2032). Disitamab Vedotin is an antibody–d...

The global Ribociclib Succinate Tablets market size is expected to reach $ 8448 million by 2032, rising at a market growth of 16.4% CAGR during the forecast period (2026-2032). In 2025, global Ribocic...

The global Selicrelumab market size is expected to reach $ 122 million by 2032, rising at a market growth of 8.9% CAGR during the forecast period (2026-2032). In 2025, global Sailiximab production rea...